CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells

Adoptive transfer of T cells genetically modified to express a cancer-specific T-cell receptor (TCR) has shown significant therapeutic potential for both hematological and solid tumors. However, a major issue of transducing T cells with a transgenic TCR is the preexisting expression of TCRs in the r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood
Autors principals: Legut, Mateusz, Dolton, Garry, Mian, Afsar Ali, Ottmann, Oliver G., Sewell, Andrew K.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2018
Matèries:
Gene Therapy
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5774207/
https://ncbi.nlm.nih.gov/pubmed/29122757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-05-787598
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars